The largest database of trusted experimental protocols

15 protocols using anti cd62l mel 14

1

Isolation and Analysis of Hepatic and Splenic Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes from fresh livers and spleens were prepared essentially as previously reported.26 (link) Briefly, excised liver from recipient mice was passed gently through a 200 μm steel mesh using a sterile syringe plunger. The liver cell suspension was collected, washed in PBS, and centrifuged for 10 min at 500 × g. The pellet was resuspended in 40% Percoll (GE Healthcare). The cell suspension was gently overlaid onto 70% Percoll and centrifuged for 25 min at 750 × g. Mononuclear cells were collected from the interface. Splenic cells were obtained from homogenized splenic tissue and filtered through a sieve. Contaminating red blood cells were lysed using red blood cells lysis buffer (BioLegend) and washed twice in PBS. Single cell suspensions obtained from the spleen and liver were subjected to flow cytometry analysis to detect surface antigens. The antibodies used to identify specific antigens were anti-CD3 (17A2), anti-CD4 (GK1.5), anti-CD8a (53-6.7), anti-CD44 (IM7), and anti-CD62L (MEL-14; all from BioLegend). Stained samples were assessed on a BD Accuri C6 Flow Cytometer (Becton Dickinson) and data analyzed using FlowJo Software (Tree Star).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The harvested spleens were mashed and single-cell suspensions of the spleens were stained with the following surface antibodies: anti-CD45 (30-F11, BD Biosciences), LIVE/DEAD Fixable Blue cell stain (Invitrogen), anti-CD19 (ID3, BD Biosciences), anti-CD8a (53-6.7, BioLegend), anti-CD27 (LG7F9, eBioscience), anti-CD11b (M1/70, BioLegend), anti-CD11c (HL3, BD Biosciences), anti-CD86 (GL1, BioLegend), anti-NK1.1 (PK136, BioLegend), anti-NKp46 (29A1.4, BioLegend), anti-MHC Class II (M5/114.15.2, BD Biosciences), anti-F4/80 (BM8, BioLegend), anti-CD80 (16-10A1), anti-CD3 (17A2, BioLegend), anti-CD4 (RM4-5, Invitrogen), anti-CTLA-4 (UC10-4B9, BioLegend), anti-PD-1 (29F.1A12, eBioscience), anti-CD28 (37.51, BioLegend), anti-CD44 (IM7, BD Biosciences), anti-CD43 (1B11, BioLegend), anti-CD47 (miap301, BioLegend), anti-CD62L (MEL-14, BioLegend), anti-CD25 (PC61.5, eBioscience), and anti-CD107a (1D4B, BioLegend). Intracellular staining was then performed with a FOXP3 permeabilization and fixation kit (eBioscience) according to manufacturer’s recommendations using the following antibodies: Ki-67 (B56; BD Biosciences) and GrB (QA16A02, BioLegend). Flow cytometric data were collected with a Beckman Coulter Cytoflex LX (6-L NUV) flow cytometer and analyzed using FlowJo software (Tree Star).
+ Open protocol
+ Expand
3

GVHD Induction and Treg Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
BALB/c mice were conditioned with total body irradiation (2x400 cGy, 200 kV X-ray source; Kimtron), injected with 5x106 T-cell depleted bone marrow (TCD-BM) cells and 5x105 purified Tregs at day 0 followed by 1x106 CD4+/CD8+ conventional T cells (Tcons) from C57BL/6 or luc+ C57BL/6 mice at day +2. If stated, Tregs were incubated with purified Anti-CD62L (Mel14; BioLegend) for 1 hour at 4°C prior to injection.
+ Open protocol
+ Expand
4

Analysis of Tumor-Specific T-Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were purchased from BioLegend (San Diego, CA): anti-CD8a (53-6.7), anti-CD44 (IM7) and anti-CD62L (MEL-14). H-2Db restricted gp100 tetramer was provided from The National Institutes of Health (NIH) Tetramer Core Facility. Goat anti-mouse TGFBR2, goat IgG isotype control and recombinant mouse TGF-β1 were purchased from R&D Systems (Minneapolis, MN). Rabbit anti-goat IgG was purchased from Abcam (Cambridge, MA). Recombinant human IL-2 was purchased from PeproTech (Rocky Hill, NJ). Human gp10025-33 (KVPRNQDWL) peptide was synthesized by the University of Pittsburgh Peptide Synthesis Facility.
+ Open protocol
+ Expand
5

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples of tumor, spleen, lymph node, and blood were harvested after killing the mice. Single-cell suspensions of tumors were obtained using a Tumor Dissociation Kit (Miltenyi). The single cells were then incubated in MACS buffer (PBS supplemented with 2% FBS and 1 mM ethylenediaminetetraacetic acid [EDTA]) containing 10 µg/mL CD16/CD32 antibody (2.4G2, BD PharMingen) for 30 min at 4 °C and then stained with the antibodies. Staining reagents included anti-CD45 (30-F11, BioLegend), anti-CD45 (30-F11, BioLegend), anti-CD3 (17A2, BioLegend), anti-CD3 (17A2, BioLegend), anti-CD4 (RM4-5, BioLegend), anti-CD8a (53-6.7, BioLegend), anti-CD25 (PC61, BioLegend), anti-CD44 (IM7, BioLegend), and anti-CD62L (MEL-14, BioLegend). Data were collected on an BD FACSAria Fusion flow cytometer and analyzed with FlowJo software (TreeStar). Dead cells and cell aggregates were excluded from analyses based on a LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit (eBioscience), or DAPI, with forward scatter/side scatter characteristics. The immune cell gating strategy was as follows: T cell: CD45+ CD3+, CD4+ T cell: CD45+ CD3+ CD4+, CD8+ T cell: CD45+ CD3+ CD8+, B cell: CD45+ CD3 CD19+.
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell staining was performed using the following monoclonal antibodies: anti-CD4 (RM4-5; eBioscience), anti-CD25 (PC61.5; eBioscience), anti-CD44 (IM7; BioLegend), and anti-CD62L (MEL-14; BioLegend). For intracellular staining, cells were first re-stimulated with a cell stimulation cocktail (00-4975-03; eBioscience) for 4 h at 37°C, after which staining of cell surface markers was performed. After staining of the surface markers, the cells were fixed and permeabilized. Intracellular staining was performed using the following monoclonal antibodies: anti-IL-17A (eBio17B7; eBioscience), anti-IFN-γ (XMG1.2; eBioscience), anti-IL-4 (11B11; BioLegend), anti-IL-13 (eBio13A; eBioscience), and anti-Foxp3 (FJK-16s; eBioscience). Stained cells were detected by flow cytometry (FACSCanto II; BD Biosciences), and data were analyzed using FlowJo software version 10.0.7 (Tree Star).
+ Open protocol
+ Expand
7

Lymphocyte Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral lymph nodes and spleens from indicated mice were grinded into single cells. Cells were washed in phosphate-buffered saline containing 2% (w/v) fetal bovine serum and then stained with indicated antibodies for analysis of surface proteins. For intracellular proteins, cells were fixed and permeabilized with Pharmingen Transcription Factor Buffer Set (BD Pharmingen, 562574). Flow cytometry was performed on CytoFLEX LX (Beckman).
Antibodies used were listed as follows: anti-CD4 (GK1.5, eBioscience), anti-CD8α (53-6.7, BD Pharmingen), anti-CD44 (IM7, BioLegend), anti-CD62L (MEL-14, BioLegend), and anti-Foxp3 (150D, BioLegend).
+ Open protocol
+ Expand
8

Flow Cytometric Profiling of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometric analysis of surface proteins, 1 × 106 cells were stained with a 1:100 antibody diluted in PBS for 20 min at 4 °C. The following antibodies were used: anti-human IgG-F(ab’)2 (polyclonal, Jackson ImmunoResearch, Ely, UK), anti-CD69 (H1.2F3, Becton Dickinson, Heidelberg, Germany), anti-CD127 (SB/199, BioLegend, Koblenz, Germany), anti-CD62L (MEL-14; BioLegend), anti-CTLA4 (UC10-4B9, BioLegend), anti-GITR (DTA-1, eBioscience, Frankfurt, Germany), anti-CD25 (PC61, Becton Dickinson), anti-CD4 (RM4-5, BioLegend), anti-Thy1.1 (OX-7, BioLegend), and anti-CD8a (53-6.7; BioLegend). Fixable viability dye (eBioscience) was used. For intracellular staining, a fixation/permeabilization kit (eBioscience) and anti-Foxp3 (MF-14, BioLegend) antibodies were used (1:100, 30 min, RT).
For phenotypic analysis, a fluorescence minus one (FMO) control was performed for each marker. After measurement with the flow cytometer, cells were gated either on their Thy1.1 (for cTregs) or on their CD4 expression (nTregs). The histograms were normalized to the mode.
+ Open protocol
+ Expand
9

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed with PBS containing 0.5% BSA and incubated for 30 minutes on ice with the following antibodies: anti-CD4 (RM-4.5; eBioscience), anti-CD8 (53.6.7; BD), anti-CD44 (IM.7; BD), anti-CD25 (PC61; BD), anti-CD62L (MEL14; Biolegend), anti-TCRβ (H57-597; eBioscience), anti-TCRγδ (BD), anti-CD69 (H1.2F3; eBioscience), anti-CD11b (M1/70; BD), anti-Gr1 (RB6-8C5; eBioscience) and anti-HSA (M1/69, eBioscience). Cells were then washed in PBS with 0.5% BSA and data was collected using a Fortessa cytometer (BD Bioscience) and analyzed using FlowJo software (Treestar, Ashland, OR).
In the case of intracellular staining, cells were fixed and permeabilized using the Foxp3 buffer staining kit (eBioscience) according to the manufacturer’s instructions prior to staining for intracellular Foxp3 expression using an anti-Foxp3 antibody (FJK-16s, BD), for 30 minutes.
For Annexin V staining, cells were washed with PBS and stained with BD Pharmingen Annexin V Apoptosis Detection Kit I according to the manufacturer’s instructions.
The detection of BrdU was performed using BD Pharmingen BrdU Flow Kit according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

Immune Cell Profiling of Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were dissociated using the MACs mouse tumor dissociation kit (Miltenyl Biotec) and suspended in PBS+1% FBS. The cells were incubated in blocking buffer containing 1:200 CD16/32(clone 93, eBioscience) for 30 min on ice. They were subsequently stained by fluorescent-conjugated primary antibodies at previously validated concentrations for 1 hr on ice. Following three PBS+1 % FBS washes, the cells were resuspended in ice cold PBS or fixed in 1 % PFA for immediate acquisition on the LSR Fortessa at the Baylor College of Medicine FACS and Cell Sorting core. Data was further analyzed using FlowJo Software version 10.0.
The following antibodies against mouse antigens were used: anti-CD3ε (145-2C11), anti-CD4 (GK1.5), anti- CD8 (53-6.7) (all from eBioscience); anti-B220 (RA3-6B2), anti-CD11b (M1/70)), anti-CD45 (30-F11), anti- F4/80 (BM8), anti-Ly6G(IA8)(all from Tonbo); anti-CD127 (SB/199, BD Biosciences), anti-CD44 (IM7, BD Biosciences), anti-CD62L (MEL14, Biolegend), Anti-KI67(16A8, Biolegend), anti-CSF1R(AFS98, Biolegend), anti-KLRG1(2F1, Biolegend).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!